Cargando…
Selective decrease in alpha(1)-antitrypsin levels in diabetic retinopathy: Could the levels of it be playing a role in the pathophysiology of diabetic retinopathy?
BACKGROUND & OBJECTIVES: Type 2 diabetes mellitus (T2DM) is known to induce inflammation and activation of neutrophils causing the release of neutrophil elastase (NE), a pro-inflammatory proteinase. The activity of NE is regulated by endogenous inhibitors alpha(1)-antitrypsin (α(1)-AT) and alpha...
Autores principales: | Kunder, Mamatha, Lakshmaiah, V., Kutty, A.V. Moideen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903389/ https://www.ncbi.nlm.nih.gov/pubmed/36124492 http://dx.doi.org/10.4103/ijmr.IJMR_1293_19 |
Ejemplares similares
-
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
por: Ortiz, Gustavo, et al.
Publicado: (2014) -
Pathophysiology of Diabetic Retinopathy
por: Tarr, Joanna M., et al.
Publicado: (2013) -
Diabetic Retinopathy: Pathophysiology and Treatments
por: Wang, Wei, et al.
Publicado: (2018) -
Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy
por: Qian, Haohua, et al.
Publicado: (2011) -
Pathophysiology of Diabetic Retinopathy: The Old and the New
por: Kusuhara, Sentaro, et al.
Publicado: (2018)